on Apex Fundrock Limited (isin : GB00B06GNN57)
Apex Fundrock Limited's Form 8.3 Disclosure on Advanced Medical Sol Group PLC
Apex Fundrock Limited, through Chelverton Asset Management, has filed a Form 8.3 disclosure regarding its position in Advanced Medical Sol Group PLC. This filing, dated 22 May 2026, includes the opening position as of 21 May 2026.
The disclosure reveals Chelverton Asset Management's interest of 1.36% in Advanced Medical Sol Group, encompassing 3,000,033 ordinary shares. The form does not report any short positions, cash-settled derivatives, or stock-settled derivatives related to these securities.
No dealings in additional securities or new subscription rights were included in the statement. The disclosure also confirms the absence of any indemnity agreements, options, or derivatives-related arrangements involving voting rights with other parties.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Apex Fundrock Limited news